Skip to main content
. Author manuscript; available in PMC: 2013 May 3.
Published in final edited form as: Psychiatr Genet. 2009 Apr;19(2):91–98. doi: 10.1097/YPG.0b013e3283208026

Table V.

Substance Dependence Regression Analyses Adjusted for Exposure Data

Classification Scheme AD1 ND2 Model 1 ND3 Model 2 CD4
Subjects Excluded 5 251 53 185
Haplotype 2 Only
 Male <0.83 <0.71 <0.24 <0.67
 Female <0.18 <0.13 <0.02 <0.43
 Combined <0.25 <0.33 <0.28 <0.43
Haplotype 3 Only
 Male <0.31 <0.005 <0.23 <0.17
 Female <0.22 <0.31 <0.38 <0.31
 Combined <0.13 <0.001 <0.14 <0.08
Haplotypes 2 & 3
 Male <0.38 <0.54 <0.76 <0.22
 Female <0.03 <0.02 <0.002 <0.13
 Combined <0.03 <0.04 <0.04 <0.06
Haplotypes 2, 3 & 4
 Male <0.22 <0.86 <0.91 <0.06
 Female <0.04 <0.002 <0.005 <0.09
 Combined <0.03 <0.03 <0.02 <0.02
Haplotypes 2, 3 & 6
 Male <0.84 <0.24 <0.91 <0.35
 Female <0.04 <0.03 <0.004 <0.24
 Combined <0.09 <0.02 <0.05 <0.15

Bolded values are significant at p<0.05. All values are not corrected for multiple comparisons.

1

Five subjects report a history of never having ingested alcohol.

2

Two hundred fifty one subjects deny smoking at least 100 cigarettes. These subjects were excluded from the analysis under this model.

3

Fifty three subjects deny ever having smoked a cigarette. These subjects were excluded from the analysis under this model.

4

One hundred eighty five subjects deny ever having smoked cannabis.

HHS Vulnerability Disclosure